The American Journal of Medicine
Volume 123, Issue 5 , Pages 417-419 , May 2010

Unraveling a Sticky Paradox

  • Evan P. Kransdorf, MD, PhD
  • ,
  • Murat O. Arcasoy, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Murat O. Arcasoy, MD, Department of Medicine, Duke University School of Medicine, DUMC Box 3912, Durham, NC 27710

References 

  1. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258–271
  2. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008;22:1–15
  3. Havouis S, Dumas G, Chambaud I, et al. Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis. Eur J Immunol. 2002;32:1147–1156
  4. Gertz MA. Management of cold haemolytic syndrome. Br J Haematol. 2007;138:422–429
  5. Berentsen S, Beiske K, Tjonnfjord GE. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Hematology. 2007;12:361–370
  6. Ulvestad E, Berentsen S, Mollnes TE. Acute phase haemolysis in chronic cold agglutinin disease. Scand J Immunol. 2001;54(1-2):239–242
  7. Vitolo U, Ferreri AJ, Montoto S. Lymphoplasmacytic lymphoma: Waldenstrom's macroglobulinemia. Crit Rev Oncol Hematol. 2008;67:172–185
  8. Dimopoulos MA, Gertz MA, Kastritis E, et al. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. J Clin Oncol. 2009;27:120–126
  9. Petz LD. A physician's guide to transfusion in autoimmune haemolytic anaemia. Br J Haematol. 2004;124:712–716
  10. Berentsen S, Ulvestad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004;103:2925–2928
  11. Schollkopf C, Kjeldsen L, Bjerrum OW, et al. Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma. 2006;47:253–260

 Aimee K. Zaas, MD, Section Editor

 Funding: None.

 Conflict of Interest: Both authors assert no relevant disclosures.

 Authorship: Both authors had access to the data and contributed to the writing of the manuscript.

PII: S0002-9343(10)00014-8

doi: 10.1016/j.amjmed.2010.01.003

The American Journal of Medicine
Volume 123, Issue 5 , Pages 417-419 , May 2010